Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00488865 · ClinicalTrials.gov registry record · NA
RexMedical- Option* Vena Cava Filter IDE Study
A NA study, sponsored by Rex Medical.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT00488865 is a NA study that has completed, run by Rex Medical. The registered enrollment target is 100 participants.
The verdict
NCT00488865, a NA study, has completed, sponsored by Rex Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
This study is designed to evaluate the safety and efficacy of the RexMedical Option\* Vena Cava Filter in the treatment of patients who are at increased risk for Pulmonary Embolism and require caval interruption.
Interventions
- DEVICE Intravascular Filter Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2006-10 |
| Est. Completion | 2009-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00488865
The ClinicalTrials.gov registry entry for NCT00488865 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rex Medical, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Intravascular Filter Device is the first listed.
NCT00488865 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00488865 about?
NCT00488865 is a clinical study titled "RexMedical- Option* Vena Cava Filter IDE Study". This study is designed to evaluate the safety and efficacy of the RexMedical Option\* Vena Cava Filter in the treatment of patients who are at increased risk for Pulmonary Embolism and require caval interruption.
What is the current status of trial NCT00488865?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2006-10. Estimated completion is 2009-06.
What interventions are being tested in trial NCT00488865?
The interventions under investigation include: Intravascular Filter Device (DEVICE).
Who is sponsoring clinical trial NCT00488865?
This trial is sponsored by Rex Medical, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.